These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


310 related items for PubMed ID: 20571484

  • 1. Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus.
    Bambico FR, Cassano T, Dominguez-Lopez S, Katz N, Walker CD, Piomelli D, Gobbi G.
    Neuropsychopharmacology; 2010 Sep; 35(10):2083-100. PubMed ID: 20571484
    [Abstract] [Full Text] [Related]

  • 2. The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus.
    Bambico FR, Duranti A, Nobrega JN, Gobbi G.
    Eur Neuropsychopharmacol; 2016 Mar; 26(3):578-90. PubMed ID: 26747370
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice.
    Cassano T, Gaetani S, Macheda T, Laconca L, Romano A, Morgese MG, Cimmino CS, Chiarotti F, Bambico FR, Gobbi G, Cuomo V, Piomelli D.
    Psychopharmacology (Berl); 2011 Mar; 214(2):465-76. PubMed ID: 21042794
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA, Kaiser N, Monory K, Lutz B.
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
    Walentiny DM, Vann RE, Wiley JL.
    Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
    [Abstract] [Full Text] [Related]

  • 8. Effect of the CB(1) receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices.
    Mendiguren A, Pineda J.
    Br J Pharmacol; 2009 Nov; 158(6):1579-87. PubMed ID: 19845674
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM.
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain.
    De Gregorio D, McLaughlin RJ, Posa L, Ochoa-Sanchez R, Enns J, Lopez-Canul M, Aboud M, Maione S, Comai S, Gobbi G.
    Pain; 2019 Jan; 160(1):136-150. PubMed ID: 30157131
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cannabinoid CB₁ receptor in the modulation of stress coping behavior in mice: the role of serotonin and different forebrain neuronal subpopulations.
    Häring M, Grieb M, Monory K, Lutz B, Moreira FA.
    Neuropharmacology; 2013 Feb; 65():83-9. PubMed ID: 23000076
    [Abstract] [Full Text] [Related]

  • 20. Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway.
    McLaughlin RJ, Hill MN, Bambico FR, Stuhr KL, Gobbi G, Hillard CJ, Gorzalka BB.
    Eur Neuropsychopharmacol; 2012 Sep; 22(9):664-71. PubMed ID: 22325231
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.